Evidence to Action Official Journal of MDCalc
Clonal Hematopoiesis Risk Score
Von Austin Wesevich.
Inhalt auf Englisch
Abstract
The Clonal Hematopoiesis Risk Score (CHRS) stratifies patients with clonal hematopoiesis of indeterminate potential (CHIP) or clonal cytopenia of undetermined significance (CCUS) into three different risk categories: low-risk (88.4%), intermediate-risk (10.5%), and high-risk (1.1%). These risk categories correspond to 10-year cumulative incidence of myeloid neoplasm of 0.7%, 7.8%, and 52.2%.